Dried blood spots can help decrease the burden on patients dually infected with multidrug-resistant tuberculosis and HIV.
University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
Marlanka A
MA
Zuur
University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands University of Groningen, University Medical Center Groningen, Tuberculosis Center Beatrixoord, Haren, The Netherlands.
Onno W
OW
Akkerman
University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands.
Daan J
DJ
Touw
University of Groningen, University Medical Center Groningen, Dept of Pulmonary Diseases and Tuberculosis, Groningen, The Netherlands University of Groningen, University Medical Center Groningen, Dept of Internal Medicine, Groningen, The Netherlands.
Tjip S
TS
van der Werf
Dept of Global Health, Academic Medical Centre, University of Amsterdam, Amsterdam, The Netherlands Radboud University Medical Center, Dept of Pharmacy, Radboud Institute for Health Sciences, Nijmegen, The Netherlands Center of Tropical Medicine and Travel Medicine, Dept of Infectious Diseases, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Frank
F
Cobelens
Radboud University Medical Center, Dept of Pharmacy, Radboud Institute for Health Sciences, Nijmegen, The Netherlands.
David M
DM
Burger
Center of Tropical Medicine and Travel Medicine, Dept of Infectious Diseases, Division of Internal Medicine, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Martin P
MP
Grobusch
University of Groningen, University Medical Center Groningen, Dept of Clinical Pharmacy and Pharmacology, Groningen, The Netherlands j.w.c.alffenaar@umcg.nl.
Jan-Willem C
JW
Alffenaar
D044966:Anti-Retroviral Agents / Q000627:therapeutic use*; D000995:Antitubercular Agents / Q000627:therapeutic use*; D060085:Coinfection; D059788:Dried Blood Spot Testing; D016903:Drug Monitoring; D015658:HIV Infections / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D006801:Humans; D018088:Tuberculosis, Multidrug-Resistant / Q000097:blood / Q000150:complications / Q000188:drug therapy*
D044966:Anti-Retroviral Agents; D000995:Antitubercular Agents